Home Newsfeeds CNBC Halftime Report Final Trades: EQT Corp., Eli Lilly, Quest Diagnostics & Northrop Grumman

CNBC Halftime Report Final Trades: EQT Corp., Eli Lilly, Quest Diagnostics & Northrop Grumman

– CNBC

byBenzinga Newsdesk

September 30, 2022

1 minute read

– CNBC

Luminar Day: Unveiling New Tech, Exclusive Partnerships, Roadmap

By Happy Mohamed

February 28, 2:31 PM

Industry CEOs and Company Execs Discuss Luminar's Vision, Execution, and The Automotive Revolution for Next-Generation Safety and Autonomy News Summary: Unveiling new Iris+ sensor; 300 meter ranging

LAZR

Keybanc Maintains Overweight on Roku, Lowers Price Target to $80

By Benzinga Newsdesk

July 29, 4:35 AM

Keybanc analyst Justin Patterson maintains Roku (NASDAQ:ROKU) with a Overweight and lowers the price target from $105 to $80.

ROKU

Volcon To Power Its Off-Road UTVs With General Motors’ Electric Propulsion Systems

By Shivani Kumaresan

August 12, 11:21 AM

Volcon Inc (NASDAQ:VLCN) plans to power all of its off-road utility terrain vehicles (UTV) with General Motors’ electric propulsion systems. The…

VLCN

InflaRx Submits Request For Emergency Use Authorization To US FDA For Vilobelimab For Treatment Of Critically Ill COVID-19 Patients

By Benzinga Newsdesk

September 29, 7:35 AM

Company also earns FDA Fast Track designation for vilobelimab to treat critically ill COVID-19 patients EUA submission based on Phase III results in critically ill COVID-19 patients, recently published in The

IFRX

CNBC Halftime Report Final Trades: EQT Corp., Eli Lilly, Quest Diagnostics & Northrop Grumman

Related Posts

Luminar Day: Unveiling New Tech, Exclusive Partnerships, Roadmap

Keybanc Maintains Overweight on Roku, Lowers Price Target to $80

Volcon To Power Its Off-Road UTVs With General Motors’ Electric Propulsion Systems

InflaRx Submits Request For Emergency Use Authorization To US FDA For Vilobelimab For Treatment Of Critically Ill COVID-19 Patients